Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
113,7 USD | +0,16 % | +1,93 % | +3,26 % |
Resumen de negocios
- sistemas e instrumentos de diagnóstico (39,1%);
- dispositivos vasculares (24,7%): sistemas endoprotésicos, catéteres de dilatación, cierres arteriales, etc;
- productos de nutrición (12,1%): productos de nutrición pediátrica, suplementos nutricionales y productos dietéticos;
- medicina (8,2%): anestésicos, productos antivirales, antibióticos, inhibidores, antiinflamatorios, etc;
- otros (15,9%).
Las ventas netas se distribuyen geográficamente del siguiente modo: Estados Unidos (38,5%), Alemania (5,8%), China (5,6%), India (4,4%), Suiza (4,1%), Japón (3,8%), Países Bajos (2,7%) y otros (35,1%).
Número de empleados: 114 000
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Medical Devices
42,1
%
| 14 687 | 33,6 % | 16 887 | 42,1 % | +14,98 % |
Diagnostic Products
24,9
%
| 16 584 | 38,0 % | 9 988 | 24,9 % | -39,77 % |
Nutritional Products
20,3
%
| 7 459 | 17,1 % | 8 154 | 20,3 % | +9,32 % |
Established Pharmaceutical Products
12,6
%
| 4 912 | 11,3 % | 5 066 | 12,6 % | +3,14 % |
Other
0,0
%
| 11 | 0,0 % | 14 | 0,0 % | +27,27 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
38,5
%
| 18 142 | 41,6 % | 15 452 | 38,5 % | -14,83 % |
All Other Countries
35,1
%
| 14 841 | 34,0 % | 14 084 | 35,1 % | -5,10 % |
Germany
5,8
%
| 2 340 | 5,4 % | 2 345 | 5,8 % | +0,21 % |
China
5,6
%
| 2 133 | 4,9 % | 2 253 | 5,6 % | +5,63 % |
India
4,4
%
| 1 649 | 3,8 % | 1 750 | 4,4 % | +6,12 % |
Switzerland
4,1
%
| 1 336 | 3,1 % | 1 638 | 4,1 % | +22,60 % |
Japan
3,8
%
| 1 932 | 4,4 % | 1 513 | 3,8 % | -21,69 % |
Netherlands
2,7
%
| - | - | 1 074 | 2,7 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 01/01/15 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 01/01/97 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/90 |
Melissa Brotz
IRO | Public Communications Contact | - | - |
Jim Leffelman
PRN | Corporate Officer/Principal | - | - |
Andrea Wainer
PRN | Corporate Officer/Principal | - | 01/01/97 |
Corporate Officer/Principal | - | 01/01/97 | |
Kathryn Collins
LAW | General Counsel | - | 01/01/99 |
John McCoy
AUD | Comptroller/Controller/Auditor | 54 | 01/01/18 |
Hubert Allen
LAW | General Counsel | 58 | 01/01/06 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 16/02/17 |
John Stratton
BRD | Director/Board Member | 63 | 29/06/17 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 09/12/11 |
Robert Alpern
BRD | Director/Board Member | 73 | 10/10/08 |
Michael Roman
BRD | Director/Board Member | 64 | 23/04/21 |
Michael O'Grady
BRD | Director/Board Member | 58 | 28/04/23 |
Robert Ford
CEO | Chief Executive Officer | 50 | 01/01/15 |
Sally E. Blount
BRD | Director/Board Member | 62 | 09/12/11 |
Michelle Kumbier
BRD | Director/Board Member | 56 | 08/06/18 |
Darren McDew
BRD | Director/Board Member | 63 | 09/09/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 988 991 783 | 1 725 727 406 ( 86,76 %) | 253 807 494 ( 12,76 %) | 86,76 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
ABBOTT INDIA LIMITED 74.99% | 15 934 048 | 74.99% | 5 457 869 544 $ |
76 259 451 | 77.90% | 128 869 321 $ | |
17 949 800 | 51.69% | 40 924 108 $ | |
ALLERGY THERAPEUTICS PLC 2.98% | 142 136 143 | 2.98% | 4 315 253 $ |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Medical Specialties
| |
Cozart Ltd.
Cozart Ltd. Medical SpecialtiesHealth Technology Cozart Ltd. designs and manufactures diagnostics products. Its products are used to test for the presence of various drugs of abuse, such as opiates, cocaine, amphetamine, methamphetamine and cannabis. The company also offers laboratory services providing screening and confirmation services in samples including oral fluid, urine, and blood. Cozart was founded by Dr. Christopher William Hand and Philip Hand in 1993 and is located in Abingdon, the United Kingdom. |
Medical Specialties
|
Abbott Toxicology Ltd.
Abbott Toxicology Ltd. Medical SpecialtiesHealth Technology Abbott Toxicology Ltd. provides drug and alcohol testing products and services. It offers advisory services and testing capabilities, including laboratory testings, point of care tests and sample types for any biological specimen, including urine, oral fluids, hair and sweat. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. |
Medical Specialties
|
Pharmaceuticals: Major
| |
Abbott Established Products Holdings (Gibraltar) Ltd.
| |
Pharmaceuticals: Major
| |
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. |
Pharmaceuticals: Major
|
Laboratoires Fournier SAS
Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Laboratoires Fournier SAS manufactures pharmaceutical preparations. The company was founded on July 10, 2007 and is headquartered in Rungis, France. |
Pharmaceuticals: Major
|
Abbott Cardiovascular Systems, Inc.
Abbott Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA. |
Medical Specialties
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,26 % | 197 mil M | |
+5,79 % | 116 mil M | |
+1,48 % | 71,49 mil M | |
+11,77 % | 53,47 mil M | |
+18,31 % | 48,42 mil M | |
+6,33 % | 43,64 mil M | |
+12,38 % | 28,97 mil M | |
+9,76 % | 28,47 mil M | |
+10,35 % | 27,78 mil M | |
+18,09 % | 27,08 mil M |
- Bolsa
- Acciones
- Acción Abbott Laboratories - Nyse
- Empresa Abbott Laboratories